Comerica Bank
EVMN

Comerica Bank’s Evommune Inc EVMN Stock Holding History

Comerica Bank’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$330 Buy
+20
New +$376 ﹤0.01% 3658

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $1.02B AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Comerica Bank's EVMN Position: Q4 2025 in Review

Comerica Bank opened a new position in Evommune Inc (EVMN) in Q4 2025: 20 shares worth $330. The stake represents ﹤0.01% of the portfolio and ranks #3658 among its holdings.

59 funds tracked by Wall St. Rank hold EVMN as of Q4 2025.

  • Comerica Bank held 20 shares of Evommune Inc worth $330 as of Q4 2025.
  • Evommune Inc was a new Comerica Bank position in Q4 2025.
  • Evommune Inc made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3658 holding.
  • 59 funds tracked by Wall St. Rank held Evommune Inc as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.